[HTML][HTML] Myosin with hypertrophic cardiac mutation R712L has a decreased working stroke which is rescued by omecamtiv mecarbil

A Snoberger, B Barua, JL Atherton, H Shuman… - Elife, 2021 - elifesciences.org
Hypertrophic cardiomyopathies (HCMs) are the leading cause of acute cardiac failure in
young individuals. Over 300 mutations throughout β-cardiac myosin, including in the motor …

[HTML][HTML] Myosin with hypertrophic cardiac mutation R712L has a decreased working stroke which is rescued by omecamtiv mecarbil

A Snoberger, B Barua, JL Atherton, H Shuman… - eLife, 2021 - ncbi.nlm.nih.gov
Hypertrophic cardiomyopathies (HCMs) are the leading cause of acute cardiac failure in
young individuals. Over 300 mutations throughout β-cardiac myosin, including in the motor …

Myosin with hypertrophic cardiac mutation R712L has a decreased working stroke which is rescued by omecamtiv mecarbil.

A Snoberger, B Barua, JL Atherton, H Shuman… - eLife, 2021 - search.ebscohost.com
Hypertrophic cardiomyopathies (HCMs) are the leading cause of acute cardiac failure in
young individuals. Over 300 mutations throughout b-cardiac myosin, including in the motor …

Myosin with hypertrophic cardiac mutation R712L has a decreased working stroke which is rescued by omecamtiv mecarbil

S Aaron, B Bipasha, JL Atherton, H Shuman, E Forgacs… - eLife, 2021 - search.proquest.com
Hypertrophic cardiomyopathies (HCMs) are the leading cause of acute cardiac failure in
young individuals. Over 300 mutations throughout β-cardiac myosin, including in the motor …

Myosin with hypertrophic cardiac mutation R712L has a decreased working stroke which is rescued by omecamtiv mecarbil

A Snoberger, B Barua, JL Atherton, H Shuman… - 2021 - agris.fao.org
Hypertrophic cardiomyopathies (HCMs) are the leading cause of acute cardiac failure in
young individuals. Over 300 mutations throughout β-cardiac myosin, including in the motor …

[PDF][PDF] Myosin with hypertrophic cardiac mutation R712L has a decreased working stroke which is rescued by omecamtiv mecarbil

A Snoberger, B Barua, JL Atherton, H Shuman… - pdfs.semanticscholar.org
Hypertrophic cardiomyopathies (HCMs) are the leading cause of acute cardiac failure in
young individuals. Over 300 mutations throughout b-cardiac myosin, including in the motor …

Myosin with hypertrophic cardiac mutation R712L has a decreased working stroke which is rescued by omecamtiv mecarbil.

A Snoberger, B Barua, JL Atherton, H Shuman… - Elife, 2021 - europepmc.org
Hypertrophic cardiomyopathies (HCMs) are the leading cause of acute cardiac failure in
young individuals. Over 300 mutations throughout β-cardiac myosin, including in the motor …

Myosin with hypertrophic cardiac mutation R712L has a decreased working stroke which is rescued by omecamtiv mecarbil

A Snoberger, B Barua, JL Atherton, H Shuman… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Hypertrophic cardiomyopathies (HCMs) are the leading cause of acute cardiac failure in
young individuals. Over 300 mutations throughout β-cardiac myosin, including in the motor …

Myosin with hypertrophic cardiac mutation r712l has a decreased working stroke which is rescued by omecamtiv mecarbil

A Snoberger, B Barua, JL Atherton, H Shuman… - eLife, 2021 - researchwithrutgers.com
Hypertrophic cardiomyopathies (HCMs) are the leading cause of acute cardiac failure in
young individuals. Over 300 mutations throughout b-cardiac myosin, including in the motor …

Myosin with hypertrophic cardiac mutation R712L has a decreased working stroke which is rescued by omecamtiv mecarbil

A Snoberger, B Barua, JL Atherton, H Shuman… - eLife, 2021 - cir.nii.ac.jp
抄録< jats: p> Hypertrophic cardiomyopathies (HCMs) are the leading cause of acute
cardiac failure in young individuals. Over 300 mutations throughout β-cardiac myosin …